Bristol-Myers Squibb

Vertex, Bristol-Myers enter agreement for Phase 2 studies of VX-135, daclatasvir
Yahoo/Fly on the Wall
Fri, 04/5/13 - 10:25 am
VX-135
Vertex Pharmaceuticals
Bristol-Myers Squibb
daclatasvir
hepatitis C
Yervoy-Zelboraf combo trial stopped on toxicity worries
Fierce Pharma
Thu, 04/4/13 - 02:05 pm
Zelboraf
Yervoy
Bristol-Myers Squibb
melanoma
Roche
Bristol-Myers to close Amylin's headquarters in San Diego and cut about 300 jobs
Yahoo/AP
Thu, 04/4/13 - 01:49 pm
Amylin
Bristol-Myers Squibb
layoffs
Celgene's Rich Pipeline Offers Growth
Seeking Alpha
Thu, 04/4/13 - 09:13 am
Celgene
Eli Lilly
Bristol-Myers Squibb
Roche
ONYX Pharmaceuticals
Pomalyst
Revlimid
Abraxane
A Clouded Future For Big Pharma's Blockbuster Diabetes Drugs
Seeking Alpha
Wed, 04/3/13 - 10:48 am
diabetes
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Novo Nordisk
Merck
Incretin
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Arena Pharmaceuticals
Zogenix
Delcath
Aveo Pharmaceutical
Vivus
Titan Pharmaceuticals
Bristol-Myers Squibb
Merck
Gilead
AbbVie
Amarin
Achillion
Sangamo BioSciences
Raptor Pharmaceuticals
Vertex Pharmaceuticals
NewLink Genetics
AstraZeneca
Rigel
Depomed
Biogen Idec
Sucampo
Dendreon
Valeant Pharmaceuticals
GSK
Aegerion
Johnson & Johnson's New Diabetes Drug And Its Competitors
Seeking Alpha
Tue, 04/2/13 - 09:52 am
JNJ
diabetes
Invokana
Merck
Januvia
Byetta
Bristol-Myers Squibb
Understanding Why Cancer Vaccines Fail
Motley Fool
Mon, 04/1/13 - 10:46 am
cancer
vaccines
Dendreon
Provenge
Bristol-Myers Squibb
Yervoy
Sanofi
TheraCys
Four Factors Driving Amgen's Stock Price To $102
Seeking Alpha
Mon, 04/1/13 - 10:38 am
Amgen
AbbVie
Bristol-Myers Squibb
JNJ
Merck
Eli Lilly
Pfizer
Celgene's Star Drug Revlimid And Its Competitors
Seeking Alpha
Sat, 03/30/13 - 10:57 am
Celgene
Revlimid
Multiple Myeloma
JNJ
Velcade
AbbVie
Bristol-Myers Squibb
elotuzumab
Should AstraZeneca and Bristol-Myers Squibb Get Married?
Motley Fool
Thu, 03/28/13 - 11:04 am
Bristol-Myers Squibb
AstraZeneca
M&A
Common Drug Has The Potential To Slow Aging, Boost Cancer Recovery
Forbes
Thu, 03/28/13 - 10:26 am
metformin
Shionogi
Bristol-Myers Squibb
Santarus
Ranbaxy
How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?
Seeking Alpha
Thu, 03/28/13 - 10:23 am
JNJ
FDA
Invokana
AstraZeneca
Bristol-Myers Squibb
Merck
Sanofi
Novo Nordisk
Novartis
4 Pharmaceutical Stocks to Buy Now
InvestorPlace
Sat, 03/23/13 - 10:06 am
Repros Therapeutics
JNJ
Bristol-Myers Squibb
Watson Pharmaceuticals
Bristol-Myers earnings could double by end of decade, says Goldman
Yahoo/Fly on the Wall
Fri, 03/22/13 - 10:44 am
Bristol-Myers Squibb
3 Big Concerns for the Pharmaceutical Industry
Motley Fool
Tue, 03/19/13 - 10:46 am
generics
drug pricing
Bristol-Myers Squibb
Eli Lilly
GSK
Questcor
KV Pharmaceutical
Sinovac Biotech
Dendreon
BDR Pharma seeks India license for Bristol-Myers drug
Reuters
Mon, 03/18/13 - 11:00 am
BDR Pharma
India
Bristol-Myers Squibb
dasatinib
blood cancer
Why AstraZeneca Will Disappoint In 2013
Seeking Alpha
Mon, 03/18/13 - 10:51 am
AstraZeneca
AbbVie
Bristol-Myers Squibb
Merck
Pfizer
Nektar
Does Bristol-Myers' Dividend Have Room to Soar?
Motley Fool
Sat, 03/16/13 - 10:56 am
Bristol-Myers Squibb
Longer Lasting Drugs Make For Longer Lasting Profits
Seeking Alpha
Fri, 03/15/13 - 10:54 am
AntriaBio
AstraZeneca
Novo Nordisk
Sanofi
Bristol-Myers Squibb

Pages